SlideShare a Scribd company logo
1 of 2
Download to read offline
July 2014
4
SCOPE
CREASPHER is a Creathes’ proprietary technology, invol-
ving emulsion solidification by « flash freezing ». It permits
to prevent active products from oxidation, to protect flavors
and to deliver actives in specific areas (e.g.: in gastro-in-
testinal tract, on skin at a chosen temperature …). CREAS-
PHER can be used to incorporate oily substances (pure or
mixed) in an oily matrix material which can be incorporated
in aqueous phase making a stable dispersion. This techno-
logy is completely green as absolutely no chemical reaction
is involved during the encapsulation process.
CONTEXT
In food industry, problems involved are essentially related
to formulation, protection, compatibility between products,
taste masking which means directly linked to galenic and
organoleptic properties of products.
Lots of technologies already exist but frequently induce
high particle size, not indicated for therapeutical use. In this
domain, advanced technologies provide controlled and tar-
geted release without texture problems, but or not suitable
for health applications because of the benefit-risk balance:
residual solvent, CMR substances like glutaraldehyde, for-
maldehyde…
With the development of therapeutic innovations, new tech-
nologies have emerged to meet new needs (size reduction,
use of different materials ...). However, other criteria are
not met, such as small size or texture problems reduction.
Nowadays, applications related to health are not only
medical but also well-being. The aging population is brin-
ging new needs such as decrease of nutrients absorption,
change in eating habits, skin problems (dehydration)… For
these kinds of applications, risk-benefit balance could not
be valid anymore as risks are almost non-existent. As more
and more benefits need to be brought, we have to develop
other ways to integrate new functionality in products.
The issue is to develop a technology allowing vectoriza-
tion-diffusion-protection and suppress this benefit-risk
balance. Several existing technologies can meet this chal-
lenge, but problems related to texture and particle size are
still present.
AS AN ALTERNATIVE TO PRILLING
AND GELATION
CREASPHER is also an alternative to these existing tech-
nologies such as prilling, spray-drying or gelation. For
example, prilling can provide capsules with 70-100 µm mini-
mum PSD, but not suitable for food or cosmetic industries.
Through our full mastery of the particle size, very small mi-
crocapsules are obtained in the range of 0.5 to 40 µm (figure
1). By this way, issues on stability, texture or grainy touch
can be easily overcome and some specific applications can
be reached.
CREASPHER is a proprietary technology (Huilier, 2013) in-
volving emulsion solidification by “flash crystallization”. It
permits to prevent active products from oxidation, to pro-
tect flavors and to deliver actives in specific areas (e.g.: in
gastro-intestinal tract, on skin at a chosen temperature…).
CREASPHER can be used to incorporate oily substances
(pure or mixed) in an oily matrix material which can be in-
corporated in aqueous phase making a stable dispersion.
Moreover, CREASPHER does not use any chemical mecha-
nism, but only phase change phenomena. INCI formula used
is 100% indicated for food and medical applications, and
could also be used for organic products. All materials used
are completely safe, without any toxicity even concerning
surfactants. Not involving chemical reaction and secondary
product, it could also be integrate into GMP processes.
APPLICATIONS
This technology is available for several applications such as
food, animal feed, nutraceutics... PSD could be chosen from
0.5 to 40 µm, depending on the expected applications.
Microcapsules are presented in a water dispersion form
(table 1, figure 2A) and can be spray-dried. Powder form is
preferred for food use, whereas liquid form is highly used
for creams and textile deposit.
ARTICLE
CREASPHER:ANEWTECHNOLOGYDEVELOPEDFORFOODANDHEALTH
Adeline Callet, Hervé Huilier - Creathes, Belfort - France
Figure 1: SEM picture of CREASPHER capsules
Table 1: Data for CREASPHER in liquid form (slurry)
Data
Particle size distribution d(0.5) can be adjusted in 0.5 to
30 µm range
Dry content 35-40 %
pH 4.5-5
Aspect Slurry, white color, no odor
Viscosity 100 cP < < 1000 cP
July 2014
5
All materials used for CREASPHER formulation are com-
pleted indicated for food and health use (Anderson, 1986;
Feldman, 1979).
REFERENCES!
Anderson, D. M. W., « Evidence for the safety of gum arabic
(Acacia senegal (L.) Willd.) as a food additive - a brief review
», Food Additives & Contaminants, 1986, 3.3, 225-230
Feldman EB, et al., « Effects of tristearin, triolein and saf-
flower oil diets on cholesterol balance in rats. » The Journal
of Nutrition, 1979, 109 (12), 2226-2236
Huilier H., « Alternative method for microencapsulation of
active ingredients », WO2014041001 (A1), 2013
This CREASPHER powder form (table 2, figure 2B) can be
used either directly in a solid product or can be dispersed
in aqueous phases. It exists into an instant version, which
exhibits auto-dispersible properties for beverages or other
liquid products…
It can also be deposit on textile and fabrics (figure 3) for use
in medical devices (e.g.: skin moisturizing, actives delivery
…) for skin-related diseases or affections due to dehydra-
tion (dermatosis, dermatitis, ichthyosis …).
PROPERTIES AND HEALTH FRIENDLY
Stability has been checked with several core materials and
did not show any issue after 6 weeks at 40°C. Physical stabi-
lity has also been tested. Sedimentation did not occur while
creaming can occur (depending on PSD, particles density).
Release of the encapsulated core product (figure 4) can
occur: either by diffusion through the shell material in dif-
ferent scale times and intensity for volatile products (figure
5). Release preferably occurs when there is no more water
residues in the product (evaporation), and/or under pres-
sure or mechanical stimulus.
CREASPHER resists to pH conditions from 3 up to 9. Tempe-
rature stability depends on shell material properties. Typi-
cally, the temperature range is about 55-70°C (melting point
of shell material).
ARTICLE
Figure 4: Schematic representation of the content delivery
Figure 5: Fragrance release out of CREASPHER capsules
Figure 2: Optical microscopy picture of CREASPHER slurry (A)
and powder (B)
Figure 3: CREASPHER capsules on textiles (optical microscopy)
ADELINE CALLET
adeline.callet@creathes.com
Graduated at the University of Strasbourg, Adeline CAL-
LET is a chemistry engineer and has a PhD in chemistry
and physics. With a master degree in Innovation project
management, she’s now working as R&D project mana-
ger at CREATHES, providing technical solutions, espe-
cially in encapsulation and formulation.
For further information, www.creathes.com.
Table 2: Data for CREASPHER in powder form
Data
Particle size distribution
for powder
50-80 µm
Particle size distribution
for capsules
d(0,5) can be adjusted in 0.5 to
30 µm range
Humidity rate 3-7 %
Density 0.3-0.5
Aspect Powder, no color, no odor

More Related Content

What's hot (9)

Process Automation in Pharm. Industry.
Process Automation in Pharm. Industry.Process Automation in Pharm. Industry.
Process Automation in Pharm. Industry.
 
Blow fill seal technology
Blow fill seal technologyBlow fill seal technology
Blow fill seal technology
 
parenteral solution
 parenteral solution parenteral solution
parenteral solution
 
Industrial Trenning
Industrial TrenningIndustrial Trenning
Industrial Trenning
 
Glutaraldehyde
GlutaraldehydeGlutaraldehyde
Glutaraldehyde
 
Glutaraldehyde1
Glutaraldehyde1Glutaraldehyde1
Glutaraldehyde1
 
Coating technology m.pharmacy 1st year
Coating technology m.pharmacy 1st yearCoating technology m.pharmacy 1st year
Coating technology m.pharmacy 1st year
 
A ppt on prefilled syringes
A ppt on prefilled syringesA ppt on prefilled syringes
A ppt on prefilled syringes
 
PILOT PLANT DESIGN FOR TABLETS
PILOT PLANT DESIGN FOR TABLETSPILOT PLANT DESIGN FOR TABLETS
PILOT PLANT DESIGN FOR TABLETS
 

Similar to CREATHES : A new technology developed for food ans health

Bioencap innov july_2014
Bioencap innov july_2014Bioencap innov july_2014
Bioencap innov july_2014CREATHES
 
Innovative nutraceutical delivery systems & r&d capability 2014 2015
Innovative  nutraceutical delivery systems & r&d capability 2014 2015Innovative  nutraceutical delivery systems & r&d capability 2014 2015
Innovative nutraceutical delivery systems & r&d capability 2014 2015Umang Budhraja
 
Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.Neha Roy
 
Evaluation of-semisolid-dosage-forms
Evaluation of-semisolid-dosage-formsEvaluation of-semisolid-dosage-forms
Evaluation of-semisolid-dosage-formsVIJAY SINGH
 
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsFormulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsDr. Raghavendra Kumar Gunda
 
Evaluation-of-semisolid-dosage-forms.pptx
Evaluation-of-semisolid-dosage-forms.pptxEvaluation-of-semisolid-dosage-forms.pptx
Evaluation-of-semisolid-dosage-forms.pptxabcpharma33
 
Anti aging modified (2)
Anti aging modified (2)Anti aging modified (2)
Anti aging modified (2)Icaii Infotech
 
FINAL INDUSTRIAL TRAINING REPORT
FINAL INDUSTRIAL TRAINING REPORT FINAL INDUSTRIAL TRAINING REPORT
FINAL INDUSTRIAL TRAINING REPORT thakurparik024
 
An overview of encapsulation technologies for food
An overview of encapsulation technologies for foodAn overview of encapsulation technologies for food
An overview of encapsulation technologies for foodnooshin noshirvani
 
.Ophthalmic preparations
.Ophthalmic preparations.Ophthalmic preparations
.Ophthalmic preparationsMOHIT SHARMA
 
Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)Anil Deore
 
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...Valentyn Mohylyuk
 
Tablet Coating Not Only a Technical Work but also a Creative Art
Tablet Coating Not Only a Technical Work but also a Creative ArtTablet Coating Not Only a Technical Work but also a Creative Art
Tablet Coating Not Only a Technical Work but also a Creative Artijtsrd
 

Similar to CREATHES : A new technology developed for food ans health (20)

Bioencap innov july_2014
Bioencap innov july_2014Bioencap innov july_2014
Bioencap innov july_2014
 
Innovative nutraceutical delivery systems & r&d capability 2014 2015
Innovative  nutraceutical delivery systems & r&d capability 2014 2015Innovative  nutraceutical delivery systems & r&d capability 2014 2015
Innovative nutraceutical delivery systems & r&d capability 2014 2015
 
Ethosome
Ethosome Ethosome
Ethosome
 
GMP design of parenteral production facility
GMP design of parenteral production facilityGMP design of parenteral production facility
GMP design of parenteral production facility
 
Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.Project report on industrial training at albert david ltd.
Project report on industrial training at albert david ltd.
 
Microencapsulation
MicroencapsulationMicroencapsulation
Microencapsulation
 
Evaluation of-semisolid-dosage-forms
Evaluation of-semisolid-dosage-formsEvaluation of-semisolid-dosage-forms
Evaluation of-semisolid-dosage-forms
 
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving TabletsFormulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
Formulation Development and Evaluation of Carbamazepine Fast Dissolving Tablets
 
Evaluation-of-semisolid-dosage-forms.pptx
Evaluation-of-semisolid-dosage-forms.pptxEvaluation-of-semisolid-dosage-forms.pptx
Evaluation-of-semisolid-dosage-forms.pptx
 
Oral dipsersible film
Oral dipsersible filmOral dipsersible film
Oral dipsersible film
 
Anti aging modified (2)
Anti aging modified (2)Anti aging modified (2)
Anti aging modified (2)
 
FINAL INDUSTRIAL TRAINING REPORT
FINAL INDUSTRIAL TRAINING REPORT FINAL INDUSTRIAL TRAINING REPORT
FINAL INDUSTRIAL TRAINING REPORT
 
MTE 2006
MTE 2006MTE 2006
MTE 2006
 
An overview of encapsulation technologies for food
An overview of encapsulation technologies for foodAn overview of encapsulation technologies for food
An overview of encapsulation technologies for food
 
.Ophthalmic preparations
.Ophthalmic preparations.Ophthalmic preparations
.Ophthalmic preparations
 
Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)
 
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...
 
Film dosage form
Film dosage formFilm dosage form
Film dosage form
 
Artigo de validação
Artigo de validaçãoArtigo de validação
Artigo de validação
 
Tablet Coating Not Only a Technical Work but also a Creative Art
Tablet Coating Not Only a Technical Work but also a Creative ArtTablet Coating Not Only a Technical Work but also a Creative Art
Tablet Coating Not Only a Technical Work but also a Creative Art
 

More from CREATHES

CREATHES Ingredients - References and Guidelines.pdf
CREATHES Ingredients - References and Guidelines.pdfCREATHES Ingredients - References and Guidelines.pdf
CREATHES Ingredients - References and Guidelines.pdfCREATHES
 
Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d...
 Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d... Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d...
Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d...CREATHES
 
CREATHES vu par son banquier
CREATHES vu par son banquier CREATHES vu par son banquier
CREATHES vu par son banquier CREATHES
 
Chez CREATHES, les collaborateurs font notre entreprise ...
Chez CREATHES, les collaborateurs font notre entreprise ...Chez CREATHES, les collaborateurs font notre entreprise ...
Chez CREATHES, les collaborateurs font notre entreprise ...CREATHES
 
CHez CREATHES, les collaborateurs font notre Entreprise...
CHez CREATHES, les collaborateurs font notre Entreprise...CHez CREATHES, les collaborateurs font notre Entreprise...
CHez CREATHES, les collaborateurs font notre Entreprise...CREATHES
 
Congrès docteurs & entreprises 2014
Congrès docteurs & entreprises 2014Congrès docteurs & entreprises 2014
Congrès docteurs & entreprises 2014CREATHES
 
Congrès Docteurs & Entreprises 2014
Congrès Docteurs & Entreprises 2014Congrès Docteurs & Entreprises 2014
Congrès Docteurs & Entreprises 2014CREATHES
 
Asrc mag7 octobre_2014
Asrc mag7 octobre_2014Asrc mag7 octobre_2014
Asrc mag7 octobre_2014CREATHES
 
Informartion entreprise n°153 2014
Informartion entreprise n°153 2014Informartion entreprise n°153 2014
Informartion entreprise n°153 2014CREATHES
 

More from CREATHES (9)

CREATHES Ingredients - References and Guidelines.pdf
CREATHES Ingredients - References and Guidelines.pdfCREATHES Ingredients - References and Guidelines.pdf
CREATHES Ingredients - References and Guidelines.pdf
 
Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d...
 Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d... Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d...
Les collaborateurs font notre Entreprise. Voici le portait d'Adeline, Chef d...
 
CREATHES vu par son banquier
CREATHES vu par son banquier CREATHES vu par son banquier
CREATHES vu par son banquier
 
Chez CREATHES, les collaborateurs font notre entreprise ...
Chez CREATHES, les collaborateurs font notre entreprise ...Chez CREATHES, les collaborateurs font notre entreprise ...
Chez CREATHES, les collaborateurs font notre entreprise ...
 
CHez CREATHES, les collaborateurs font notre Entreprise...
CHez CREATHES, les collaborateurs font notre Entreprise...CHez CREATHES, les collaborateurs font notre Entreprise...
CHez CREATHES, les collaborateurs font notre Entreprise...
 
Congrès docteurs & entreprises 2014
Congrès docteurs & entreprises 2014Congrès docteurs & entreprises 2014
Congrès docteurs & entreprises 2014
 
Congrès Docteurs & Entreprises 2014
Congrès Docteurs & Entreprises 2014Congrès Docteurs & Entreprises 2014
Congrès Docteurs & Entreprises 2014
 
Asrc mag7 octobre_2014
Asrc mag7 octobre_2014Asrc mag7 octobre_2014
Asrc mag7 octobre_2014
 
Informartion entreprise n°153 2014
Informartion entreprise n°153 2014Informartion entreprise n°153 2014
Informartion entreprise n°153 2014
 

Recently uploaded

Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...apidays
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024Rafal Los
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Drew Madelung
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAndrey Devyatkin
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century educationjfdjdjcjdnsjd
 
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live StreamsTop 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live StreamsRoshan Dwivedi
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoffsammart93
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Miguel Araújo
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationRadu Cotescu
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)Gabriella Davis
 
Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024SynarionITSolutions
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsJoaquim Jorge
 
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...Principled Technologies
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024The Digital Insurer
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherRemote DBA Services
 

Recently uploaded (20)

Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024The 7 Things I Know About Cyber Security After 25 Years | April 2024
The 7 Things I Know About Cyber Security After 25 Years | April 2024
 
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
Strategies for Unlocking Knowledge Management in Microsoft 365 in the Copilot...
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live StreamsTop 5 Benefits OF Using Muvi Live Paywall For Live Streams
Top 5 Benefits OF Using Muvi Live Paywall For Live Streams
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
Scaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organizationScaling API-first – The story of a global engineering organization
Scaling API-first – The story of a global engineering organization
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)A Domino Admins Adventures (Engage 2024)
A Domino Admins Adventures (Engage 2024)
 
Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024Top 10 Most Downloaded Games on Play Store in 2024
Top 10 Most Downloaded Games on Play Store in 2024
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
Deploy with confidence: VMware Cloud Foundation 5.1 on next gen Dell PowerEdg...
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024Manulife - Insurer Innovation Award 2024
Manulife - Insurer Innovation Award 2024
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 

CREATHES : A new technology developed for food ans health

  • 1. July 2014 4 SCOPE CREASPHER is a Creathes’ proprietary technology, invol- ving emulsion solidification by « flash freezing ». It permits to prevent active products from oxidation, to protect flavors and to deliver actives in specific areas (e.g.: in gastro-in- testinal tract, on skin at a chosen temperature …). CREAS- PHER can be used to incorporate oily substances (pure or mixed) in an oily matrix material which can be incorporated in aqueous phase making a stable dispersion. This techno- logy is completely green as absolutely no chemical reaction is involved during the encapsulation process. CONTEXT In food industry, problems involved are essentially related to formulation, protection, compatibility between products, taste masking which means directly linked to galenic and organoleptic properties of products. Lots of technologies already exist but frequently induce high particle size, not indicated for therapeutical use. In this domain, advanced technologies provide controlled and tar- geted release without texture problems, but or not suitable for health applications because of the benefit-risk balance: residual solvent, CMR substances like glutaraldehyde, for- maldehyde… With the development of therapeutic innovations, new tech- nologies have emerged to meet new needs (size reduction, use of different materials ...). However, other criteria are not met, such as small size or texture problems reduction. Nowadays, applications related to health are not only medical but also well-being. The aging population is brin- ging new needs such as decrease of nutrients absorption, change in eating habits, skin problems (dehydration)… For these kinds of applications, risk-benefit balance could not be valid anymore as risks are almost non-existent. As more and more benefits need to be brought, we have to develop other ways to integrate new functionality in products. The issue is to develop a technology allowing vectoriza- tion-diffusion-protection and suppress this benefit-risk balance. Several existing technologies can meet this chal- lenge, but problems related to texture and particle size are still present. AS AN ALTERNATIVE TO PRILLING AND GELATION CREASPHER is also an alternative to these existing tech- nologies such as prilling, spray-drying or gelation. For example, prilling can provide capsules with 70-100 µm mini- mum PSD, but not suitable for food or cosmetic industries. Through our full mastery of the particle size, very small mi- crocapsules are obtained in the range of 0.5 to 40 µm (figure 1). By this way, issues on stability, texture or grainy touch can be easily overcome and some specific applications can be reached. CREASPHER is a proprietary technology (Huilier, 2013) in- volving emulsion solidification by “flash crystallization”. It permits to prevent active products from oxidation, to pro- tect flavors and to deliver actives in specific areas (e.g.: in gastro-intestinal tract, on skin at a chosen temperature…). CREASPHER can be used to incorporate oily substances (pure or mixed) in an oily matrix material which can be in- corporated in aqueous phase making a stable dispersion. Moreover, CREASPHER does not use any chemical mecha- nism, but only phase change phenomena. INCI formula used is 100% indicated for food and medical applications, and could also be used for organic products. All materials used are completely safe, without any toxicity even concerning surfactants. Not involving chemical reaction and secondary product, it could also be integrate into GMP processes. APPLICATIONS This technology is available for several applications such as food, animal feed, nutraceutics... PSD could be chosen from 0.5 to 40 µm, depending on the expected applications. Microcapsules are presented in a water dispersion form (table 1, figure 2A) and can be spray-dried. Powder form is preferred for food use, whereas liquid form is highly used for creams and textile deposit. ARTICLE CREASPHER:ANEWTECHNOLOGYDEVELOPEDFORFOODANDHEALTH Adeline Callet, Hervé Huilier - Creathes, Belfort - France Figure 1: SEM picture of CREASPHER capsules Table 1: Data for CREASPHER in liquid form (slurry) Data Particle size distribution d(0.5) can be adjusted in 0.5 to 30 µm range Dry content 35-40 % pH 4.5-5 Aspect Slurry, white color, no odor Viscosity 100 cP < < 1000 cP
  • 2. July 2014 5 All materials used for CREASPHER formulation are com- pleted indicated for food and health use (Anderson, 1986; Feldman, 1979). REFERENCES! Anderson, D. M. W., « Evidence for the safety of gum arabic (Acacia senegal (L.) Willd.) as a food additive - a brief review », Food Additives & Contaminants, 1986, 3.3, 225-230 Feldman EB, et al., « Effects of tristearin, triolein and saf- flower oil diets on cholesterol balance in rats. » The Journal of Nutrition, 1979, 109 (12), 2226-2236 Huilier H., « Alternative method for microencapsulation of active ingredients », WO2014041001 (A1), 2013 This CREASPHER powder form (table 2, figure 2B) can be used either directly in a solid product or can be dispersed in aqueous phases. It exists into an instant version, which exhibits auto-dispersible properties for beverages or other liquid products… It can also be deposit on textile and fabrics (figure 3) for use in medical devices (e.g.: skin moisturizing, actives delivery …) for skin-related diseases or affections due to dehydra- tion (dermatosis, dermatitis, ichthyosis …). PROPERTIES AND HEALTH FRIENDLY Stability has been checked with several core materials and did not show any issue after 6 weeks at 40°C. Physical stabi- lity has also been tested. Sedimentation did not occur while creaming can occur (depending on PSD, particles density). Release of the encapsulated core product (figure 4) can occur: either by diffusion through the shell material in dif- ferent scale times and intensity for volatile products (figure 5). Release preferably occurs when there is no more water residues in the product (evaporation), and/or under pres- sure or mechanical stimulus. CREASPHER resists to pH conditions from 3 up to 9. Tempe- rature stability depends on shell material properties. Typi- cally, the temperature range is about 55-70°C (melting point of shell material). ARTICLE Figure 4: Schematic representation of the content delivery Figure 5: Fragrance release out of CREASPHER capsules Figure 2: Optical microscopy picture of CREASPHER slurry (A) and powder (B) Figure 3: CREASPHER capsules on textiles (optical microscopy) ADELINE CALLET adeline.callet@creathes.com Graduated at the University of Strasbourg, Adeline CAL- LET is a chemistry engineer and has a PhD in chemistry and physics. With a master degree in Innovation project management, she’s now working as R&D project mana- ger at CREATHES, providing technical solutions, espe- cially in encapsulation and formulation. For further information, www.creathes.com. Table 2: Data for CREASPHER in powder form Data Particle size distribution for powder 50-80 µm Particle size distribution for capsules d(0,5) can be adjusted in 0.5 to 30 µm range Humidity rate 3-7 % Density 0.3-0.5 Aspect Powder, no color, no odor